Estrogen Metabolism in Patients with EGFR-Mutated and ALK-Mutated Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Bodor, J. N. [1 ]
Treat, J. [1 ]
Krzizike, D. D. [1 ]
Zawislak, C. L. [1 ]
Vanderveer, L. [1 ]
Yulis, M. [1 ]
Chau, A. [1 ]
Ross, E. A. [1 ]
Andrews, A. J. [1 ]
Clapper, M. L. [1 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A20
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [1] Profile of Reactive Estrogen Species in Women with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Bodor, J. N.
    Krzizike, D. D.
    Vanderveer, L.
    Eidbo, S.
    Zawislak, C. L.
    Ross, E. A.
    Andrews, A. J.
    Edelman, M. J.
    Treat, J.
    Clapper, M. L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S75 - S75
  • [2] Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
    Thompson, Jonathan R.
    Menon, Smitha P.
    Dy, Grace K.
    [J]. ADMET AND DMPK, 2016, 4 (03): : 186 - 211
  • [3] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
    Cardona, A.
    Arrieta, O.
    Rojas, L.
    Zatarain-Barron, Z.
    Ricaurte, L.
    Ruiz-Patino, A.
    Martin, C.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
  • [5] Treatment strategy of EGFR-mutated non-small cell lung cancer
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    Kuroda, Koji
    [J]. JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 602 - 606
  • [6] Emerging drugs for EGFR-mutated non-small cell lung cancer
    Sukrithan, Vineeth
    Deng, Lei
    Barbar, Alexander
    Cheng, Haiying
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (01) : 5 - 16
  • [7] How to Treat EGFR-Mutated Non-Small Cell Lung Cancer
    Belani, Neel
    Liang, Katherine
    Fradley, Michael
    Judd, Julia
    Borghaei, Hossein
    [J]. JACC: CARDIOONCOLOGY, 2023, 5 (04): : 542 - 545
  • [8] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [9] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [10] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
12345